Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Tsuda

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|August 6, 2008
Synthesis of somatostatin analogues containing C-terminal adamantane and their antiproliferative propertiesAnna Miyazaki, Yuko Tsuda, Shoji Fukushima, et al.
Biochimica Et Biophysica Acta|November 16, 2004
The structure-activity relationship of various YO compounds, novel plasmin inhibitors, in the apoptosis inductionRiyo Enomoto, Chiyoko Sugahara, Tomoe Komai, et al.
Bioorganic & Medicinal Chemistry|April 30, 2015
Novel type of plasmin inhibitors: providing insight into P4 moiety and alternative scaffold to pyrrolopyrimidineNaoki Teno, Keigo Gohda, Keiko Wanaka, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 20, 2004
Application of liquid chromatography-tandem mass spectrometry for the determination of opioidmimetics in the brain dialysates from rats treated with opioidmimetics intraperitoneallyKazuo Igarashi, Yuki Murabayashi, Koichiro Hotta, et al.
Chemical & Pharmaceutical Bulletin|September 6, 2005
Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenationAnna Miyazaki, Yutaka Fujisawa, Kimitaka Shiotani, et al.
Journal of Medicinal Chemistry|January 22, 2005
Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2Tingyou Li, Yoshio Fujita, Yuko Tsuda, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platformKimitaka Shiotani, Tingyou Li, Anna Miyazaki, et al.
Bioorganic & Medicinal Chemistry|April 3, 2003
Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bondYoshio Okada, Yoshio Fujita, Takashi Motoyama, et al.
European Journal of Pharmacology|February 17, 2005
Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouseYunden Jinsmaa, Yoshio Fujita, Kimitaka Shiotani, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Synthesis of opioidmimetics, 3-[H-Dmt-NH(CH(2))(m)]-6-[H-Dmt-NH(CH(2))(n)]-2(1H)-pyrazinones, and studies on structure-activity relationshipsKimitaka Shiotani, Anna Miyazaki, Tingyou Li, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|August 6, 2008
Synthesis of somatostatin analogues containing C-terminal adamantane and their antiproliferative propertiesAnna Miyazaki, Yuko Tsuda, Shoji Fukushima, et al.
Biochimica Et Biophysica Acta|November 16, 2004
The structure-activity relationship of various YO compounds, novel plasmin inhibitors, in the apoptosis inductionRiyo Enomoto, Chiyoko Sugahara, Tomoe Komai, et al.
Bioorganic & Medicinal Chemistry|April 30, 2015
Novel type of plasmin inhibitors: providing insight into P4 moiety and alternative scaffold to pyrrolopyrimidineNaoki Teno, Keigo Gohda, Keiko Wanaka, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 20, 2004
Application of liquid chromatography-tandem mass spectrometry for the determination of opioidmimetics in the brain dialysates from rats treated with opioidmimetics intraperitoneallyKazuo Igarashi, Yuki Murabayashi, Koichiro Hotta, et al.
Chemical & Pharmaceutical Bulletin|September 6, 2005
Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenationAnna Miyazaki, Yutaka Fujisawa, Kimitaka Shiotani, et al.
Journal of Medicinal Chemistry|January 22, 2005
Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2Tingyou Li, Yoshio Fujita, Yuko Tsuda, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platformKimitaka Shiotani, Tingyou Li, Anna Miyazaki, et al.
Bioorganic & Medicinal Chemistry|April 3, 2003
Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bondYoshio Okada, Yoshio Fujita, Takashi Motoyama, et al.
European Journal of Pharmacology|February 17, 2005
Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouseYunden Jinsmaa, Yoshio Fujita, Kimitaka Shiotani, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Synthesis of opioidmimetics, 3-[H-Dmt-NH(CH(2))(m)]-6-[H-Dmt-NH(CH(2))(n)]-2(1H)-pyrazinones, and studies on structure-activity relationshipsKimitaka Shiotani, Anna Miyazaki, Tingyou Li, et al.
Pageof 9